NCT05159024

Brief Summary

The interest in identifying a biological marker for the early detection of AL is growing. Such a marker could play a vital role in modern fast-track multimodal protocols, allowing safe and early discharge of patients after colorectal surgery with a low rate of readmission. C-reactive protein (CRP) has been identified as a valid parameter for detection of postoperative infectious complications after rectal resection. A serum CRP level greater than 12.4 mg/dL on postoperative day (POD) 4 is considered predictive of septic complications. According to a recent analysis, the changes in the trajectory of CRP levels might be more beneficial than a snipped point. Moreover, the trajectory has a negative predictability of up to 99.3%. Another interesting biomarker is procalcitonin (PCT), the prohormone of calcitonin, produced by parafollicular C cells in the thyroid. Normally, it has a very low plasma concentration in healthy individuals (0.01-0.05 ng/mL), and it increases during severe generalized bacterial, parasitic, or fungal infections, but not in noninfectious inflammatory reactions. Procalcitonin has been described as an early, sensitive, and specific marker of sepsis. Moreover, the plasma concentration of PCT has been used as an early predictor of infection in acute pancreatitis, secondary peritonitis, and infectious complications after thoracic, esophageal, and cardiac surgeries. In addition, elevated white blood cell (WBC) count is associated with AL after gastrointestinal surgeries. Therefore, this study was conducted to evaluate the utility of CRP, PCT, and WBC count trajectories, as separate and combined biomarkers for prediction of AL after colorectal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
205

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
Last Updated

July 26, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

November 18, 2021

Last Update Submit

July 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of combined CRP-PCT- WBC trajectory in prediction of anastomotic leak

    Sensitivity, specificity and accuracy of combined CRP-PCT- WBCs trajectory

    five days after surgery

Study Arms (1)

Patients with leak after colorectal anastomosis

Patients who developed anastomotic leak, clinical or radiologic, after colorectal resection and anastomosis

Diagnostic Test: CRP, PCT, and WBCs trajectories

Interventions

the levels of CRP, PCT, and WBCs were assessed before surgery and after the onset of leak

Patients with leak after colorectal anastomosis

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

205 patients who had colorectal surgery, all patients had a diagnosis of new or previous colorectal cancer. 56.1% of patients were males and 43.9% were females. Patient age ranged from 25 to 78 years, with a mean of 56.4 years

You may qualify if:

  • adult patients of either sex who underwent colorectal surgery entailing an anastomosis

You may not qualify if:

  • Patients younger than 18 years
  • Patients with active infection at the time of surgery
  • Patients who had received chemotherapy or radiotherapy
  • Patients on long-term corticosteroid therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

MeSH Terms

Conditions

Anastomotic Leak

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of surgery

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 15, 2021

Study Start

March 1, 2018

Primary Completion

March 1, 2020

Study Completion

April 30, 2020

Last Updated

July 26, 2024

Record last verified: 2024-07

Locations